maropitant has been researched along with ziprasidone in 1 studies
Studies (maropitant) | Trials (maropitant) | Recent Studies (post-2010) (maropitant) | Studies (ziprasidone) | Trials (ziprasidone) | Recent Studies (post-2010) (ziprasidone) |
---|---|---|---|---|---|
74 | 36 | 56 | 1,068 | 254 | 362 |
Protein | Taxonomy | maropitant (IC50) | ziprasidone (IC50) |
---|---|---|---|
D(2) dopamine receptor | Homo sapiens (human) | 0.005 | |
Aspartate aminotransferase, cytoplasmic | Homo sapiens (human) | 5.39 | |
D | Rattus norvegicus (Norway rat) | 0.1514 | |
Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.1514 | |
Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.1514 | |
Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.1514 | |
Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 0.1514 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.011 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.0004 | |
Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.011 | |
Alpha-1B adrenergic receptor | Homo sapiens (human) | 0.011 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.2301 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sebestyén, Z; Szabó, B; Szepesi, K | 1 |
1 review(s) available for maropitant and ziprasidone
Article | Year |
---|---|
[Pharmaceutical applications of sulfobuthylether-beta-cyclodextrin].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Antiemetics; Antifungal Agents; Antipsychotic Agents; Aripiprazole; beta-Cyclodextrins; Chemistry, Pharmaceutical; Dosage Forms; Drug Stability; Humans; Hungary; Multiple Myeloma; Oligopeptides; Piperazines; Pyrimidines; Quinolones; Quinuclidines; Solubility; Thiazoles; Triazoles; Voriconazole | 2013 |